Drugs / TIV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02293317 Background | Nov 2014 → Mar 2015 | influenza | BiondVax Pharmaceuticals ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02293317 ↗ |
| Modality | Vaccine | “HA based seasonal influenza vaccine, for 2014/15 seson” NCT02293317 ↗ |
| Route | Intramuscular | “All subjects will receive an intramuscular (IM) injection, in each one of three visits, with a 21±2 days interval between treatments” NCT02293317 ↗ |